SIRT3-deficient DLBCL cells manifested global loss of TCA cycle metabolites, such as citrate, α-KG, and AcCoA, caused by impaired entry of glutamine into the TCA cycle (9). This evidence concerns the gene SIRT3 and diffuse large B-cell lymphoma.